This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

VORICONAZOLE

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20221105

Version

4

Spl Product Data Elements

VORICONAZOLE voriconazole VORICONAZOLE VORICONAZOLE SULFOBUTYLETHER .BETA.-CYCLODEXTRIN

Application Number

ANDA208983

Brand Name

VORICONAZOLE

Generic Name

voriconazole

Product Ndc

70771-1413

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Container Label NDC 70771-1413-1 Voriconazole for Injection 200 mg per vial Sterile Single-Dose Vial For Intravenous Infusion Only Rx Only PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Carton Label NDC 70771-1413-1 Voriconazole for Injection 200 mg per vial Sterile Single-Dose Vial For Intravenous Infusion Only 1 Vial Rx Only figure02 figure03

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.